Trial
NCT05401227
Glutamatergic Mechanisms: Aim2
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
National Institute of Mental Health (NIMH)
Condition
Healthy
Intervention
Ketamine
Why stopped
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-13